argus

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDYINE089A0103198,162 Cr

Timeline

Time (IST)TypeMEventSrc
22 Jun, 04:56 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation for Considering The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On June 30, 2026bse
20 Jun, 01:56 pmDr. Reddy's Laboratories Limited has informed the Exchange about Newspaper advertisement titled Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend informationnse
19 Jun, 02:23 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee stock options'.nse
13 Jun, 01:03 pmother2Dr. Reddy’s launched Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States on June 13, 2026, with exclusive U.S. marketing rights and first-to-market 180-day generic exclusivity for the 400mg strength.nse
12 Jun, 12:09 pmprocedural0Kallam Satish Reddy submitted a copy of a SEBI Takeover Regulations (Reg 31(4)) disclosure to the exchange; no transaction value or impact is stated.nse
05 Jun, 03:36 pmDr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Employee Stock Optionsnse
03 Jun, 12:05 pmDr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analyst/Investor meetnse
01 Jun, 03:38 pmDr. Reddy's Laboratories Limited has informed the Exchange aboutnse
30 May, 01:08 pmDr. Reddy's Laboratories Limited has informed the Exchange that the Annual Report in Form 20F for the fiscal year ended March 31, 2026 has been filed with United States Securities and Exchange Commission.nse
30 May, 01:03 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
28 May, 04:38 pmDr Reddys Laboratories Ltd - 500124 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
28 May, 03:31 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Dr. Reddy's Laboratories to Ring the Closing Bell® at the New York Stock Exchange.nse
28 May, 03:29 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
18 May, 09:29 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
18 May, 09:25 pmDr. Reddy's Laboratories Limited has informed the Exchange about Transcriptnse
16 May, 12:27 amDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada".nse
16 May, 12:16 amDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 May, 11:29 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 12, 2026, titled "Recordings of Earnings call".nse
12 May, 11:28 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 May, 06:38 pmDr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentationnse
12 May, 06:34 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
12 May, 06:33 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
12 May, 05:15 pmDr Reddys Laboratories Ltd - 500124 - Corporate Action-Board to consider Dividendbse
12 May, 05:10 pmDr. Reddy's Laboratories Limited has informed the Exchange about elevation of Mr. Sandeep Khandelwal as a Senior Management Personnel.nse
12 May, 05:08 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sbse
12 May, 05:07 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.nse
12 May, 05:03 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Auditors of the company.nse
12 May, 05:02 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Change in Managementbse
12 May, 04:54 pmDr Reddys Laboratories Ltd - 500124 - Fixing Of Record Date As July 10, 2026 For The Purpose Of Payment Of Final Dividend For FY 2025-26bse
12 May, 04:52 pmDr. Reddy's Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 10-Jul-2026.nse
12 May, 04:49 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
12 May, 04:46 pmDr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 12, 2026, recommended Final Dividend of Rs. 8 per equity share.nse
12 May, 04:45 pmDr Reddys Laboratories Ltd - 500124 - Audited Financial Results For The Year Ended March 31, 2026bse
12 May, 04:39 pmDr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
12 May, 04:39 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 12, 2026bse
11 May, 07:29 pmDr Reddys Laboratories Ltd - 500124 - Announcement Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015bse
11 May, 07:28 pmDr. Reddy's Laboratories Limited has informed the Exchange about Grant of Employee Stock Optionsnse
29 Apr, 09:11 amDr. Reddy's Laboratories Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsnse
29 Apr, 09:08 amDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
24 Apr, 04:49 pmDr Reddys Laboratories Ltd - 500124 - Clarification - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
24 Apr, 02:40 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
24 Apr, 02:39 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 24, 2026, titled "Intimation of Earnings call".nse
24 Apr, 09:36 amThe Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr. Reddys Laboratories still awaiting approval for a major near-term trigger, sources say. The response from the Company is attached.nse
24 Apr, 09:33 amDr Reddys Laboratories Ltd - 500124 - Clarification-Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
24 Apr, 09:13 amDr. Reddy's Laboratories Limited has informed the Exchange about Rumour Verification - Regulation 30(11)nse
23 Apr, 01:49 pmThe Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr. Reddys Laboratories still awaiting approval for a major near-term trigger, sources say. The response from the Company is awaited.nse
16 Apr, 03:43 pmDr. Reddy's Laboratories Limited has informed the Exchange about Board meeting intimation for recommending final dividend, if any, for Financial Year 2025-26nse
14 Apr, 09:17 pmDr. Reddy's Laboratories Limited has informed the Exchange about Dr. Reddy s Laboratories LLC, Russia, a step-down wholly-owned subsidiary has received a final penalty decision from the Tax Authority.nse
14 Apr, 09:10 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
07 Apr, 07:35 pmDr. Reddy's Laboratories Limited has informed the Exchange about sale of wholly owned subsidiarynse